GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Achiko AG (XSWX:ACHI) » Definitions » Capital Expenditure

Achiko AG (XSWX:ACHI) Capital Expenditure : CHF-0.22 Mil (TTM As of Jun. 2022)


View and export this data going back to 2019. Start your Free Trial

What is Achiko AG Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Achiko AG's cash flow for capital expenditures for the six months ended in Jun. 2022 was CHF-0.22 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Jun. 2022 was CHF-0.22 Mil.

Achiko AG Capital Expenditure Historical Data

The historical data trend for Achiko AG's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achiko AG Capital Expenditure Chart

Achiko AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21
Capital Expenditure
- - -0.04 -0.41

Achiko AG Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
Capital Expenditure Get a 7-Day Free Trial -0.01 -0.03 - - -0.22

Achiko AG Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Jun. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-0.22 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Achiko AG (XSWX:ACHI) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Achiko AG (XSWX:ACHI) » Definitions » Capital Expenditure
Comparable Companies
SZSE:300869 SZSE:300314 SZSE:300246 SZSE:300633 SZSE:301033 SZSE:300813 SHSE:688016 SZSE:300206 SZSE:301235 SHSE:688389 CERN VEEV TSE:2413 CHNG DOCS NUTX RCM TDOC TXG HQY
Traded in Other Exchanges
N/A
Address
Tessinerplatz 7, Zurich, CHE, CH-8002
Website
https://www.achiko.com
Achiko AG is developing disruptive diagnostic solutions that put people first. The company product is a rapid, reliable Covid-19 test with a companion app offering a user-friendly digital health passport. Achiko creates and develops aptamer-based diagnostics through its biotechnology division, AptameX, and companion health apps via its digital mobile health technology division, Teman Sehat. The AptameX DNA aptamer tests can be rapidly chemically synthesized, are cost-effective, and have wide potential across multiple disease diagnostics. Leveraging AptameX and Teman Sehat, Achiko aims to deliver fast, accurate, and affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications in the rapidly evolving healthcare diagnostics field.

Achiko AG (XSWX:ACHI) Headlines

No Headlines